Interview with Dr Roger Hayes (Cetero Research) on instrumentation and technology in bioanalysis

Roger Hayes spoke to Bioanalysis Zone in February 2011, following his appointment as President - Bioanalytical at Cetero Research. What led to your specializing in bioanalysis? I’ve always wanted to participate in the development of medicines that halted the course of life threatening and/or debilitating diseases. The pharmaceutical industry allowed me to do that, while providing the personal challenges of working with incredibly small quantities of analytes in very complex matrices using state-of-the-art technologies. What are you currently working on? I recently joined Cetero Research, a leading early phase contract research organization, after more than 10 years at Schering-Plough Research Institute,...